Select for export Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881120986422 PubMed 33740877 Copy citation Copy BibTeX Journal of Psychopharmacology 2021-03-18 Dos Santos RG, Hallak JE, Baker G, Dursun S. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans Abstract available at the source but not redistributed here. Read at source. Details DOI 10.12688/f1000research.28133.1 Copy citation Copy BibTeX F1000Res 2021-03-14 Musikaphongsakul P, Ya K, Subsoontorn P, Lohitnavy M. Europe PMC PREPRINT (not peer reviewed) psilocybinpsilocin PharmacologyReceptor Pharmacology Other More
Select for export The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2021.03.07.434103 Copy citation Copy BibTeX bioRxiv 2021-03-07 Kozłowska U, Klimczak A, Wiatr K, Figiel M. bioRxiv PREPRINT (not peer reviewed) psilocin DepressionPTSDMechanism of Action Other More
Select for export The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges. Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX DOAJ (DOAJ: Directory of Open Access Journals) 2021-03-04 Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyClinical Trial Clinical Trial More
Select for export Stroke and Adverse Effects on The Immune and Cardiovascular Systems: The Danger of the Rise and Use of Psychedelic Drugs for Depression and PTSD Abstract available at the source but not redistributed here. Read at source. Details DOI 10.33140/jcei.06.02.01 Copy citation Copy BibTeX Journal of Clinical & Experimental Immunology 2021-03-02 Authors unavailable OpenAlex Published psilocybin DepressionPTSDReceptor Pharmacology Other More
Select for export The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2021.619890 PubMed 33732156 Copy citation Copy BibTeX Unknown journal 2021-02-22 Winkelman MJ. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyConsciousness Review Article More
Select for export Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881121991822 PubMed 33611977 Copy citation Copy BibTeX Journal of Psychopharmacology 2021-02-19 Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR. Europe PMC Published psilocybin DepressionAddictionReceptor Pharmacology Other More
Select for export How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1213/ane.0000000000005349 Copy citation Copy BibTeX Anesthesia & Analgesia 2021-02-16 Peter G. Brindley OpenAlex Published psilocybinpsilocin DepressionAddictionChronic Pain Review Article More
Select for export Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2021.02.03.429325 Copy citation Copy BibTeX bioRxiv 2021-02-04 Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS bioRxiv PREPRINT (not peer reviewed) psilocybinpsilocin Brain ImagingMechanism of ActionReceptor Pharmacology Other More
Select for export Use of psilocybin (“mushrooms”) among US adults: 2015-2018 Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2020.00159 Copy citation Copy BibTeX Journal of Psychedelic Studies 2021-02-03 R. Andrew Yockey, Keith A. King OpenAlex Published psilocybin AddictionReceptor PharmacologyAging Observational Study More
Select for export Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2021.01.28.428377 Copy citation Copy BibTeX bioRxiv 2021-01-28 McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS bioRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Observational Study More
Select for export 5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.pbr.2021.01.007 PubMed 33541678 Copy citation Copy BibTeX Unknown journal 2021-01-21 Higgins GA, Sellers EM. Europe PMC Published psilocybin AddictionReceptor PharmacologyBiomarkers Animal Study More
Select for export A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ijms22020835 PubMed 33467676 Copy citation Copy BibTeX International Journal of Molecular Sciences 2021-01-14 Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD Europe PMC Published psilocybin DepressionNeuroplasticityReceptor Pharmacology Other More
Select for export Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-020-05719-1 PubMed 33427944 Copy citation Copy BibTeX Unknown journal 2021-01-10 Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D Europe PMC Published psilocybin DepressionReceptor PharmacologyClinical Trial Randomized Controlled Trial More
Select for export Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 not approved] No abstract availability was recorded for this entry. Details DOI 10.5256/f1000research.31120.r81816 Copy citation Copy BibTeX Faculty of 1000 Research Ltd 2020-12-31 Michael W. Dzierlenga OpenAlex Published psilocybinpsilocin PharmacologyReceptor PharmacologyReview Article Review Article More
Select for export Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 approved with reservations, 1 not approved] No abstract availability was recorded for this entry. Details DOI 10.5256/f1000research.31120.r81474 Copy citation Copy BibTeX Faculty of 1000 Research Ltd 2020-12-31 Quoc Ba Tran OpenAlex Published psilocybinpsilocin PharmacologyReceptor PharmacologyReview Article Review Article More
Select for export Psilocybin therapy appears as effective as escitalopram, small study finds Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1211/pj.2021.1.91592 Copy citation Copy BibTeX Pharmaceutical journal/The pharmaceutical journal 2020-12-31 Authors unavailable OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2020-12-31 Harmony I. Risca OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Animal Study More
Select for export Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1124/pharmrev.120.000056 PubMed 33328244 Copy citation Copy BibTeX Unknown journal 2020-12-31 Inserra A, De Gregorio D, Gobbi G. Europe PMC Published psilocybin PTSDNeuroplasticityMechanism of Action Clinical Trial More
Select for export How ecstasy and psilocybin are shaking up psychiatry. No abstract availability was recorded for this entry. Details DOI 10.1038/d41586-021-00187-9 PubMed 33505033 Copy citation Copy BibTeX Nature 2020-12-31 Tullis P. Europe PMC Published psilocybin DepressionNeuroplasticityReceptor Pharmacology Clinical Trial More
